Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

REGNREGN
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in REGENERON PHARMACEUTICALS

NORTHERN TRUST CORP holds 916,467 shares of REGN (REGENERON PHARMACEUTICALS), worth $571.5M as of 2026-Q2. The position was decreased (-2.7% shares). REGN represents 0.1% of NORTHERN TRUST CORP's portfolio.

Current Value

$571.5M

Current Shares

916,467

Total Value Change

-$394.3M

Total Shares Change

-2,178

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
916,467
-2.7%
$571.5M0.1%$622.81
0
2026-Q1
Decreased
941,941
-0.3%
$727.8M0.1%$770.59
0
2025-Q4
Decreased
944,933
-4.0%
$729.4M0.1%$768.90
0
2025-Q3
Increased
984,792
+2.7%
$553.7M0.1%$559.40
32
2025-Q2
Decreased
958,569
-4.3%
$503.2M0.1%$521.53
0
2025-Q1
Decreased
1M
-5.0%
$635.3M0.1%$629.11
0
2024-Q4
Increased
1.1M
+14.8%
$751.4M0.1%$705.67
43
2024-Q3
Decreased
918,645
-5.0%
$965.7M0.2%$1,041.41
0

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used